Avalo Therapeutics (AVTX) News Today $0.05 -0.01 (-15.87%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.05▼$0.0650-Day Range$0.05▼$0.1652-Week Range$0.05▼$6.09Volume15.41 million shsAverage Volume14.39 million shsMarket Capitalization$1.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAvalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock Splitfinanznachrichten.de - December 7 at 8:41 AMAvalo Encourages Stockholders to Vote FOR the Reverse Stock Splitfinance.yahoo.com - December 7 at 8:41 AMAvalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Large Increase in Short Interestamericanbankingnews.com - December 1 at 4:12 AMAvalo Therapeutics Stock (NASDAQ:AVTX) Earnings Dates and Earning Callsbenzinga.com - November 11 at 7:28 PMAvalo Therapeutics Inc AVTXmorningstar.com - November 9 at 4:21 PMAvalo Therapeutics Inc (AVTX) Announces Q3 2023 Financial Results and Strategic Advancesfinance.yahoo.com - November 9 at 11:20 AMAvalo Reports Third Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - November 9 at 11:20 AMAvalo Completes Divestiture of AVTX-800 Seriesfinance.yahoo.com - October 31 at 7:47 AMBestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeuticsfinance.yahoo.com - September 27 at 12:26 PMWhy Avalo Therapeutics Stock Is Up Todaybenzinga.com - September 26 at 3:43 PMWhat's Going On With Avalo Therapeutics (AVTX) Stock?benzinga.com - September 22 at 2:46 PMWhy Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarketbenzinga.com - September 18 at 9:22 AMWhy Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com - September 13 at 4:25 PMAvalo drops three rare disease assets amid ongoing challengesmsn.com - September 13 at 4:25 PMWhy Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarketbenzinga.com - September 13 at 9:45 AMAvalo Therapeutics Shares Rise 53% After Deal to Divest Certain Assetsmarketwatch.com - September 12 at 6:43 PMWhy Microcap Biotech Firm Avalo Therapeutics Stock Is Trading Higher Today?msn.com - September 12 at 6:43 PMCrude Oil Rises 2%; Avalo Therapeutics Shares Spike Highermarkets.businessinsider.com - September 12 at 6:43 PMAvalo Therapeutics To Sell 800 Series Programs To AUG Therapeutics; Stock Surgesmarkets.businessinsider.com - September 12 at 7:51 AMAvalo enters agreement to divest AVTX-800 seriesseekingalpha.com - September 12 at 7:51 AMAvalo Enters into Agreement to Divest AVTX-800 Seriesfinance.yahoo.com - September 12 at 7:51 AMAvalo to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 10:11 AMIs Avalo Therapeutics (AVTX) A Hidden Gem or A Value Trap?finance.yahoo.com - August 22 at 9:58 PMAvalo Therapeutics, Inc. (AVTX) Reports Q2 Loss, Misses Revenue Estimatesmsn.com - August 3 at 10:20 AMAvalo Reports Second Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - August 3 at 10:19 AMAvalo Therapeutics Stock (NASDAQ:AVTX) Insider Tradesbenzinga.com - July 26 at 3:48 PMAvalo to Participate in SVB Securities Therapeutics Forumfinance.yahoo.com - July 6 at 7:35 PMAvalo Therapeutics 10% Owner Sold $1.03M In Company Stockbenzinga.com - June 28 at 4:28 PMAvalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%msn.com - June 27 at 11:33 AMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.04%msn.com - June 26 at 7:13 PMWhy Are Avalo Therapeutics Shares Plummeting On Mondaymsn.com - June 26 at 2:12 PMAvalo Plummets 80% on Phase 2 Disappointment in Asthmamsn.com - June 26 at 2:12 PMAvalo Therapeutics Shares Hit 52-Week Low After Trial Misses Primary Endpointmarketwatch.com - June 26 at 2:12 PMmarketbeat.com - June 26 at 9:35 AMAvalo Therapeutics: Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthmafinanznachrichten.de - June 26 at 9:12 AMAvalo Therapeutics Trial for AVTX-002 Misses Primary Endpointmarketwatch.com - June 26 at 9:12 AMAvalo Therapeutics: AVTX-002 Fails To Meet Primary Endpoint In Phase 2 PEAK Trialmarkets.businessinsider.com - June 26 at 9:12 AMAvalo Therapeutics Shares Drop 85% After Trial for AVTX-002 Misses Primary Endpointmarketwatch.com - June 26 at 9:12 AMAvalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthmafinance.yahoo.com - June 26 at 9:12 AMmarketbeat.com - June 26 at 6:59 AMAvalo to Present at the Jefferies Healthcare Conferencefinance.yahoo.com - June 1 at 10:18 AMAvalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Boardfinance.yahoo.com - May 22 at 8:50 AMAvalo Therapeutics: Avalo Reports First Quarter 2023 Financial Results and Provides Business Updatesfinanznachrichten.de - May 18 at 8:38 AMChief Financial Officer at Avalo Therapeutics Acquires Company Stock Options Worth 40,000 Sharesbenzinga.com - May 17 at 3:12 PMAvalo to Present at ATS 2023 Respiratory Innovation Summitfinance.yahoo.com - May 15 at 7:30 AMAvalo to Present at the 2023 RBC Capital Markets Global Healthcare Conferencefinance.yahoo.com - May 10 at 8:05 AMAvalo Therapeutics GAAP EPS of -$0.85, revenue of $0.48Mseekingalpha.com - May 6 at 10:39 PMAvalo Therapeutics, Inc. (AVTX) Reports Q1 Loss, Lags Revenue Estimatesmsn.com - May 4 at 8:30 PMAvalo Reports First Quarter 2023 Financial Results and Provides Business Updatesfinance.yahoo.com - May 4 at 8:30 PMCambyz Golestaneh Just Bought 4.0% More Shares In Avalo Therapeutics, Inc. (NASDAQ:AVTX)finance.yahoo.com - April 13 at 10:36 AM Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTX Media Mentions By Week AVTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVTX News Sentiment▼1.300.51▲Average Medical News Sentiment AVTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVTX Articles This Week▼21▲AVTX Articles Average Week Get Avalo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AVTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GRI Bio News Today Altamira Therapeutics News Today Ampio Pharmaceuticals News Today NexImmune News Today JanOne News Today InMed Pharmaceuticals News Today Comera Life Sciences News Today Histogen News Today PaxMedica News Today Bellicum Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:AVTX) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.